A phase II study of pembrolizumab combination with temozolomide as 1L treatment for Chinese metastatic acral melanoma patients

被引：0
|
作者：
Ding, Y. [1 ]
Xu, Y. [2 ]
Zhang, X. [1 ]
Chen, Y. [2 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Dept Biotherapy, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
[2] Fudan Univ, Dept Musculoskeletal Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1131P
引用
收藏
页码：S743 / S743
页数：1
相关论文
共 50 条
  • [31] A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma
    Damian A. Laber
    Roseline I. Okeke
    Carlos Arce-Lara
    Beverly S. Taft
    Cassandra L. Schonard
    Kelly M. McMasters
    Goetz H. Kloecker
    Donald M. Miller
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 611 - 616
  • [32] A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma
    Laber, Damian A.
    Okeke, Roseline I.
    Arce-Lara, Carlos
    Taft, Beverly S.
    Schonard, Cassandra L.
    McMasters, Kelly M.
    Kloecker, Goetz H.
    Miller, Donald M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (09) : 611 - 616
  • [33] Phase I/II study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma
    Kim, K. B.
    Davies, M. A.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Hwu, W.
    Woodard, K.
    Washington, E. W.
    Dancey, J. E.
    Wright, J.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma
    Garcia, Margarita
    del Muro, Xavier Garcia
    Tres, Alejandro
    Crespo, Carmen
    Valladares, Manuel
    Lopez, Juan Jose
    Rifa, Julio
    Perez, Xavier
    Filipovich, Elena
    Germa-Lluch, Josep Ramon
    MELANOMA RESEARCH, 2006, 16 (04) : 365 - 370
  • [35] Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup
    Ridolfi, R
    Romanini, A
    Sileni, VC
    Michiara, M
    Guida, M
    Biasco, G
    Poletti, P
    Amaducci, L
    Leoni, M
    Ravaioli, A
    MELANOMA RESEARCH, 2004, 14 (04) : 295 - 299
  • [36] Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy
    Robert, C.
    Chaput, N.
    Lassau, N.
    Auperin, A.
    Koscielny, S.
    Hollville, E.
    Lazar, V.
    Lacroix, L.
    Soria, J.
    Mateus, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma
    Middleton, M. R.
    Friedlander, P.
    Hamid, O.
    Daud, A.
    Plummer, R.
    Falotico, N.
    Chyla, B.
    Jiang, F.
    McKeegan, E.
    Mostafa, N. M.
    Zhu, M.
    Qian, J.
    McKee, M.
    Luo, Y.
    Giranda, V. L.
    McArthur, G. A.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2173 - 2179
  • [38] Final report: Combination of MPC-6827 with temozolomide for the treatment of patients with metastatic melanoma
    Hwu, W.
    Akerley, W. L.
    Stephenson, J.
    Yu, M. K.
    Evans, B. A.
    Mather, G.
    Swabb, E. A.
    Hamid, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] PHASE-II STUDY OF AMSA ALONE AND IN COMBINATION WITH DTIC IN PATIENTS WITH METASTATIC MELANOMA
    POLYZOS, A
    LEGHA, SS
    BURGESS, AM
    BENJAMIN, RS
    BODEY, GP
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (01) : 57 - 61
  • [40] Temozolomide in combination with docetaxel in patients with advanced melanoma: A phase II study of the Hellenic Cooperative Oncology Group
    Bafaloukos, D
    Gogas, H
    Georgoulias, V
    Briassoulis, E
    Fountzilas, G
    Samantas, E
    Kalofonos, C
    Skarlos, D
    Karabelis, A
    Kosmidis, P
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 420 - 425
12345